Multivalent Vaccines Market Report

China Multivalent Vaccines Industry Market Research Report 2023-2029

  • POSTDATE：Sep 04, 2023
  • PAGES：163
  • REPORT CODE：GMM1775723
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Multivalent Vaccines industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Bavarian Nordic (Denmark)

    • Emergent BioSolutions, Inc (US)

    • Serum Institute of India Pvt Ltd (India)

    • Johnson & Johnson (US)

    • Merck & Co, Inc (US)

    • GlaxoSmithKline, plc (UK)

    • MedImmune, LLC (US)

    • Pfizer, Inc (US)

    • Sanofi Pasteur SA (France)

    • Astellas Pharma Inc (Japan)

    • Panacea Biotec (India)

    • Daiichi Sankyo (Japan)

    • CSL Limited (Australia)

    By Type:

    • Conjugate Vaccines

    • Inactivated and Subunit Vaccines

    • Recombinant Vaccines

    • Live Attenuated Vaccines

    • Toxoid Vaccines

    By Application:

    • Adults

    • Pediatrics

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Multivalent Vaccines Market Overview 2018-2029

    • 1.1 China Multivalent Vaccines Industry Development Overview

    • 1.2 China Multivalent Vaccines Industry Development History

    • 1.3 China Multivalent Vaccines Industry Market Size (2018-2029)

    • 1.4 China Multivalent Vaccines Market Analysis by Type from Production Side

      • 1.4.1 China Multivalent Vaccines Production Volume, Production Value and Growth Rate of Conjugate Vaccines (2018-2029)

      • 1.4.2 China Multivalent Vaccines Production Volume, Production Value and Growth Rate of Inactivated and Subunit Vaccines (2018-2029)

      • 1.4.3 China Multivalent Vaccines Production Volume, Production Value and Growth Rate of Recombinant Vaccines (2018-2029)

      • 1.4.4 China Multivalent Vaccines Production Volume, Production Value and Growth Rate of Live Attenuated Vaccines (2018-2029)

      • 1.4.5 China Multivalent Vaccines Production Volume, Production Value and Growth Rate of Toxoid Vaccines (2018-2029)

    • 1.5 China Multivalent Vaccines Market Analysis by Application from Consumption End

      • 1.5.1 China Multivalent Vaccines Sales Volume, Sales Value and Growth Rate of Adults (2018-2029)

      • 1.5.2 China Multivalent Vaccines Sales Volume, Sales Value and Growth Rate of Pediatrics (2018-2029)

    • 1.6 China Multivalent Vaccines Market Analysis by Region

      • 1.6.1 North China Multivalent Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Multivalent Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Multivalent Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Multivalent Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Multivalent Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Multivalent Vaccines Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Multivalent Vaccines Market Size and Growth Rate from 2018-2029

    Chapter 2 China Multivalent Vaccines Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Multivalent Vaccines Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Multivalent Vaccines Market Status and Competition Analysis in 2023

      • 2.2.3 China Multivalent Vaccines Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Multivalent Vaccines Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Multivalent Vaccines Industry Development

    Chapter 3 Multivalent VaccinesIndustry Chain Analysis

    • 3.1 Multivalent Vaccines Industry Chain

    • 3.2 Multivalent Vaccines Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Multivalent Vaccines Market

    • 3.3 Multivalent Vaccines Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Multivalent Vaccines Market

    Chapter 4 China Multivalent Vaccines Market, by Type

    • 4.1 China Multivalent Vaccines Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Multivalent Vaccines Total Production Volume and Growth Rate from Production Side

    • 4.5 China Multivalent Vaccines Production Volume and Growth Rate, by Type

      • 4.5.1 China Multivalent Vaccines Production Volume and Growth Rate of Conjugate Vaccines

      • 4.5.2 China Multivalent Vaccines Production Volume and Growth Rate of Inactivated and Subunit Vaccines

      • 4.5.3 China Multivalent Vaccines Production Volume and Growth Rate of Recombinant Vaccines

      • 4.5.4 China Multivalent Vaccines Production Volume and Growth Rate of Live Attenuated Vaccines

      • 4.5.5 China Multivalent Vaccines Production Volume and Growth Rate of Toxoid Vaccines

    Chapter 5 China Multivalent Vaccines Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Multivalent Vaccines Total Market Size and Growth Rate from Consumption End

    • 5.5 China Multivalent Vaccines Market Size and Growth Rate, by Application

      • 5.5.1 China Multivalent Vaccines Market Size and Growth Rate of Adults

      • 5.5.2 China Multivalent Vaccines Market Size and Growth Rate of Pediatrics

    Chapter 6 China Multivalent Vaccines Market, by Region

    • 6.1 China Multivalent Vaccines Production Volume and Production Value, by Region

    • 6.2 China Multivalent Vaccines Sales Volume and Sales Value, by Region

    Chapter 7 North China Multivalent Vaccines Market Analysis

    • 7.1 North China Multivalent Vaccines Market, by Type

    • 7.2 North China Multivalent Vaccines Market, by Application

    Chapter 8 Central China Multivalent Vaccines Market Analysis

    • 8.1 Central China Multivalent Vaccines Market, by Type

    • 8.2 Central China Multivalent Vaccines Market, by Application

    Chapter 9 South China Multivalent Vaccines Market Analysis

    • 9.1 South China Multivalent Vaccines Market, by Type

    • 9.2 South China Multivalent Vaccines Market, by Application

    Chapter 10 East China Multivalent Vaccines Market Analysis

    • 10.1 East China Multivalent Vaccines Market, by Type

    • 10.2 East China Multivalent Vaccines Market, by Application

    Chapter 11 Northeast China Multivalent Vaccines Market Analysis

    • 11.1 Northeast China Multivalent Vaccines Market, by Type

    • 11.2 Northeast China Multivalent Vaccines Market, by Application

    Chapter 12 Southwest China Multivalent Vaccines Market Analysis

    • 12.1 Southwest China Multivalent Vaccines Market, by Type

    • 12.2 Southwest China Multivalent Vaccines Market, by Application

    Chapter 13 Northwest China Multivalent Vaccines Market Analysis

    • 13.1 Northwest China Multivalent Vaccines Market, by Type

    • 13.2 Northwest China Multivalent Vaccines Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Bavarian Nordic (Denmark)

        • 14.1.1 Bavarian Nordic (Denmark) Company Profile

        • 14.1.2 Bavarian Nordic (Denmark) Multivalent Vaccines Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Emergent BioSolutions, Inc (US)

        • 14.2.1 Emergent BioSolutions, Inc (US) Company Profile

        • 14.2.2 Emergent BioSolutions, Inc (US) Multivalent Vaccines Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Serum Institute of India Pvt Ltd (India)

        • 14.3.1 Serum Institute of India Pvt Ltd (India) Company Profile

        • 14.3.2 Serum Institute of India Pvt Ltd (India) Multivalent Vaccines Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Johnson & Johnson (US)

        • 14.4.1 Johnson & Johnson (US) Company Profile

        • 14.4.2 Johnson & Johnson (US) Multivalent Vaccines Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Merck & Co, Inc (US)

        • 14.5.1 Merck & Co, Inc (US) Company Profile

        • 14.5.2 Merck & Co, Inc (US) Multivalent Vaccines Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 GlaxoSmithKline, plc (UK)

        • 14.6.1 GlaxoSmithKline, plc (UK) Company Profile

        • 14.6.2 GlaxoSmithKline, plc (UK) Multivalent Vaccines Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 MedImmune, LLC (US)

        • 14.7.1 MedImmune, LLC (US) Company Profile

        • 14.7.2 MedImmune, LLC (US) Multivalent Vaccines Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Pfizer, Inc (US)

        • 14.8.1 Pfizer, Inc (US) Company Profile

        • 14.8.2 Pfizer, Inc (US) Multivalent Vaccines Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Sanofi Pasteur SA (France)

        • 14.9.1 Sanofi Pasteur SA (France) Company Profile

        • 14.9.2 Sanofi Pasteur SA (France) Multivalent Vaccines Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Astellas Pharma Inc (Japan)

        • 14.10.1 Astellas Pharma Inc (Japan) Company Profile

        • 14.10.2 Astellas Pharma Inc (Japan) Multivalent Vaccines Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Panacea Biotec (India)

        • 14.11.1 Panacea Biotec (India) Company Profile

        • 14.11.2 Panacea Biotec (India) Multivalent Vaccines Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Daiichi Sankyo (Japan)

        • 14.12.1 Daiichi Sankyo (Japan) Company Profile

        • 14.12.2 Daiichi Sankyo (Japan) Multivalent Vaccines Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 CSL Limited (Australia)

        • 14.13.1 CSL Limited (Australia) Company Profile

        • 14.13.2 CSL Limited (Australia) Multivalent Vaccines Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Multivalent Vaccines Industry Research Conclusions

    • 15.2 Multivalent Vaccines Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Multivalent Vaccines Industry Market Size (2018-2029)

    • Figure China Multivalent Vaccines Production Volume, Production Value and Growth Rate of Conjugate Vaccines (2018-2029)

    • Figure China Multivalent Vaccines Production Volume, Production Value and Growth Rate of Inactivated and Subunit Vaccines (2018-2029)

    • Figure China Multivalent Vaccines Production Volume, Production Value and Growth Rate of Recombinant Vaccines (2018-2029)

    • Figure China Multivalent Vaccines Production Volume, Production Value and Growth Rate of Live Attenuated Vaccines (2018-2029)

    • Figure China Multivalent Vaccines Production Volume, Production Value and Growth Rate of Toxoid Vaccines (2018-2029)

    • Figure China Multivalent Vaccines Sales Volume, Sales Value and Growth Rate of Adults (2018-2029)

    • Figure China Multivalent Vaccines Sales Volume, Sales Value and Growth Rate of Pediatrics (2018-2029)

    • Figure North China Multivalent Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Central China Multivalent Vaccines Market Size and Growth Rate from 2018-2029

    • Figure South China Multivalent Vaccines Market Size and Growth Rate from 2018-2029

    • Figure East China Multivalent Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Multivalent Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Multivalent Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Multivalent Vaccines Market Size and Growth Rate from 2018-2029

    • Figure Multivalent Vaccines Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Multivalent Vaccines Market Share by Type in 2018

    • Figure China Multivalent Vaccines Market Share by Type in 2023

    • Figure China Multivalent Vaccines Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Multivalent Vaccines Production Volume and Growth Rate of Conjugate Vaccines (2018-2023)

    • Figure China Multivalent Vaccines Production Volume and Growth Rate of Inactivated and Subunit Vaccines (2018-2023)

    • Figure China Multivalent Vaccines Production Volume and Growth Rate of Recombinant Vaccines (2018-2023)

    • Figure China Multivalent Vaccines Production Volume and Growth Rate of Live Attenuated Vaccines (2018-2023)

    • Figure China Multivalent Vaccines Production Volume and Growth Rate of Toxoid Vaccines (2018-2023)

    • Figure China Multivalent Vaccines Market Share by Application in 2018

    • Figure China Multivalent Vaccines Market Share by Application in 2023

    • Figure China Multivalent Vaccines Total Market Size and Growth Rate from Consumption End

    • Figure China Multivalent Vaccines Market Size and Growth Rate of Adults (2018-2023)

    • Figure China Multivalent Vaccines Market Size and Growth Rate of Pediatrics (2018-2023)

    • Table China Multivalent Vaccines Production Volume by Region (2018-2023)

    • Table China Multivalent Vaccines Production Volume Share by Region (2018-2023)

    • Figure China Multivalent Vaccines Production Volume Share by Region (2018-2023)

    • Table China Multivalent Vaccines Production Value by Region (2018-2023)

    • Table China Multivalent Vaccines Production Value Share by Region (2018-2023)

    • Figure China Multivalent Vaccines Production Value Share by Region (2018-2023)

    • Table China Multivalent Vaccines Sales Volume by Region (2018-2023)

    • Table China Multivalent Vaccines Sales Volume Share by Region (2018-2023)

    • Figure China Multivalent Vaccines Sales Volume Share by Region (2018-2023)

    • Table China Multivalent Vaccines Sales Value by Region (2018-2023)

    • Table China Multivalent Vaccines Sales Value Share by Region (2018-2023)

    • Figure China Multivalent Vaccines Sales Value Share by Region (2018-2023)

    • Table North China Multivalent Vaccines Production Volume by Type (2018-2023)

    • Table North China Multivalent Vaccines Production Volume Share by Type (2018-2023)

    • Figure North China Multivalent Vaccines Production Volume Share by Type (2018-2023)

    • Table North China Multivalent Vaccines Sales Volume by Application (2018-2023)

    • Table North China Multivalent Vaccines Sales Volume Share by Application (2018-2023)

    • Figure North China Multivalent Vaccines Sales Volume Share by Application (2018-2023)

    • Table Central China Multivalent Vaccines Production Volume by Type (2018-2023)

    • Table Central China Multivalent Vaccines Production Volume Share by Type (2018-2023)

    • Figure Central China Multivalent Vaccines Production Volume Share by Type (2018-2023)

    • Table Central China Multivalent Vaccines Sales Volume by Application (2018-2023)

    • Table Central China Multivalent Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Central China Multivalent Vaccines Sales Volume Share by Application (2018-2023)

    • Table South China Multivalent Vaccines Production Volume by Type (2018-2023)

    • Table South China Multivalent Vaccines Production Volume Share by Type (2018-2023)

    • Figure South China Multivalent Vaccines Production Volume Share by Type (2018-2023)

    • Table South China Multivalent Vaccines Sales Volume by Application (2018-2023)

    • Table South China Multivalent Vaccines Sales Volume Share by Application (2018-2023)

    • Figure South China Multivalent Vaccines Sales Volume Share by Application (2018-2023)

    • Table East China Multivalent Vaccines Production Volume by Type (2018-2023)

    • Table East China Multivalent Vaccines Production Volume Share by Type (2018-2023)

    • Figure East China Multivalent Vaccines Production Volume Share by Type (2018-2023)

    • Table East China Multivalent Vaccines Sales Volume by Application (2018-2023)

    • Table East China Multivalent Vaccines Sales Volume Share by Application (2018-2023)

    • Figure East China Multivalent Vaccines Sales Volume Share by Application (2018-2023)

    • Table Northeast China Multivalent Vaccines Production Volume by Type (2018-2023)

    • Table Northeast China Multivalent Vaccines Production Volume Share by Type (2018-2023)

    • Figure Northeast China Multivalent Vaccines Production Volume Share by Type (2018-2023)

    • Table Northeast China Multivalent Vaccines Sales Volume by Application (2018-2023)

    • Table Northeast China Multivalent Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Multivalent Vaccines Sales Volume Share by Application (2018-2023)

    • Table Southwest China Multivalent Vaccines Production Volume by Type (2018-2023)

    • Table Southwest China Multivalent Vaccines Production Volume Share by Type (2018-2023)

    • Figure Southwest China Multivalent Vaccines Production Volume Share by Type (2018-2023)

    • Table Southwest China Multivalent Vaccines Sales Volume by Application (2018-2023)

    • Table Southwest China Multivalent Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Multivalent Vaccines Sales Volume Share by Application (2018-2023)

    • Table Northwest China Multivalent Vaccines Production Volume by Type (2018-2023)

    • Table Northwest China Multivalent Vaccines Production Volume Share by Type (2018-2023)

    • Figure Northwest China Multivalent Vaccines Production Volume Share by Type (2018-2023)

    • Table Northwest China Multivalent Vaccines Sales Volume by Application (2018-2023)

    • Table Northwest China Multivalent Vaccines Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Multivalent Vaccines Sales Volume Share by Application (2018-2023)

    • Table Bavarian Nordic (Denmark) Company Profile

    • Table Bavarian Nordic (Denmark) Multivalent Vaccines Revenue, Price and Gross (2018-2023)

    • Table Emergent BioSolutions, Inc (US) Company Profile

    • Table Emergent BioSolutions, Inc (US) Multivalent Vaccines Revenue, Price and Gross (2018-2023)

    • Table Serum Institute of India Pvt Ltd (India) Company Profile

    • Table Serum Institute of India Pvt Ltd (India) Multivalent Vaccines Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson (US) Company Profile

    • Table Johnson & Johnson (US) Multivalent Vaccines Revenue, Price and Gross (2018-2023)

    • Table Merck & Co, Inc (US) Company Profile

    • Table Merck & Co, Inc (US) Multivalent Vaccines Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline, plc (UK) Company Profile

    • Table GlaxoSmithKline, plc (UK) Multivalent Vaccines Revenue, Price and Gross (2018-2023)

    • Table MedImmune, LLC (US) Company Profile

    • Table MedImmune, LLC (US) Multivalent Vaccines Revenue, Price and Gross (2018-2023)

    • Table Pfizer, Inc (US) Company Profile

    • Table Pfizer, Inc (US) Multivalent Vaccines Revenue, Price and Gross (2018-2023)

    • Table Sanofi Pasteur SA (France) Company Profile

    • Table Sanofi Pasteur SA (France) Multivalent Vaccines Revenue, Price and Gross (2018-2023)

    • Table Astellas Pharma Inc (Japan) Company Profile

    • Table Astellas Pharma Inc (Japan) Multivalent Vaccines Revenue, Price and Gross (2018-2023)

    • Table Panacea Biotec (India) Company Profile

    • Table Panacea Biotec (India) Multivalent Vaccines Revenue, Price and Gross (2018-2023)

    • Table Daiichi Sankyo (Japan) Company Profile

    • Table Daiichi Sankyo (Japan) Multivalent Vaccines Revenue, Price and Gross (2018-2023)

    • Table CSL Limited (Australia) Company Profile

    • Table CSL Limited (Australia) Multivalent Vaccines Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US